David Teboul Shares NIH Research: Translating Cryo-EM Structures into Therapeutic Insights for Heart Disease
David Teboul, Life Sciences Electron Microscopy Account Manager at Thermo Fisher Scientific, posted on LinkedIn:
“New Research: Clinical Samples Used in Cryo-EM Study of LDL Metabolism
Researchers at National Institute of Allergy and Infectious Diseases (NIAID) and National Heart, Lung, and Blood Institute have used clinical samples in cryo-electron microscopy (cryo-EM) to explore mechanisms of lipid metabolism. One of the lead authors, Dr. Altaira Dearborn, a staff scientist in Dr. Joseph Marcotrigiano’s lab at NIAID (NIH), is working to use “real-world” samples—applying cryo-EM single particle analysis to proteins directly isolated from human patients to uncover disease mechanisms at near-atomic resolution.
This study sheds new light on LDL (low-density lipoprotein) recognition and uptake. The findings not only deepen our understanding of cholesterol metabolism but also offer promising directions for therapeutic development in atherosclerosis and related cardiovascular diseases.
A great example of how structural biology and translational research can converge to impact human health.”
Title: Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor
Authors: Mart Reimund, Altaira D. Dearborn, Giorgio Graziano, Haotian Lei, Anthony M. Ciancone, Ashish Kumar, Ronald Holewinski, Edward B. Neufeld, Francis J. O’Reilly, Alan T. Remaley, Joseph Marcotrigiano
Read full article here.
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS